Literature DB >> 25586990

Successful rapid desensitization to the antibody-drug conjugate brentuximab vedotin in a patient with refractory Hodgkin lymphoma.

Marie Fizesan1, Christopher Boin1, Olivier Aujoulat1, Georges Newinger2, Dana Ghergus3, Hervé Watier4, Hélène Lustig1, Mario Ojeda-Uribe5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25586990     DOI： 10.1177/1078155214567164

Source DB:  PubMed          Journal:  J Oncol Pharm Pract        ISSN： 1078-1552            Impact factor:   1.809


× No keyword cloud information.
  2 in total

1.  Desensitization of Brentuximab Vedotin in a Patient with Hodgkin Lymphoma.

Authors:  Sidra Khalid; Aariez Khalid; Bernadette A Clark; Hamed Daw
Journal:  Cureus       Date:  2018-07-13

2.  Rapid desensitization for brentuximab vedotin (Adceteris®) allergy: a case report.

Authors:  Attilio Di Girolamo; Marcello Albanesi; Alessandro Sinisi; Eustachio Nettis; Danilo Di Bona; Maria Filomena Caiaffa; Luigi Macchia
Journal:  Clin Mol Allergy       Date:  2018-10-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.